ID   E2AK2_RAT               Reviewed;         513 AA.
AC   Q63184;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 151.
DE   RecName: Full=Interferon-induced, double-stranded RNA-activated protein kinase;
DE            EC=2.7.11.1;
DE   AltName: Full=Eukaryotic translation initiation factor 2-alpha kinase 2;
DE            Short=eIF-2A protein kinase 2;
DE   AltName: Full=Interferon-inducible RNA-dependent protein kinase;
DE   AltName: Full=Protein kinase RNA-activated;
DE            Short=PKR;
DE            Short=Protein kinase R {ECO:0000305};
DE   AltName: Full=Tyrosine-protein kinase EIF2AK2;
DE            EC=2.7.10.2;
GN   Name=Eif2ak2; Synonyms=Prkr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7948027; DOI=10.1016/0167-4781(94)90229-1;
RA   Mellor H., Flowers K.M., Kimball S.R., Jefferson L.S.;
RT   "Cloning and characterization of a cDNA encoding rat PKR, the double-
RT   stranded RNA-dependent eukaryotic initiation factor-2 kinase.";
RL   Biochim. Biophys. Acta 1219:693-696(1994).
RN   [2]
RP   INTERACTION WITH STRBP.
RX   PubMed=10684936; DOI=10.1093/nar/28.6.1407;
RA   Coolidge C.J., Patton J.G.;
RT   "A new double-stranded RNA-binding protein that interacts with PKR.";
RL   Nucleic Acids Res. 28:1407-1417(2000).
CC   -!- FUNCTION: IFN-induced dsRNA-dependent serine/threonine-protein kinase
CC       that phosphorylates the alpha subunit of eukaryotic translation
CC       initiation factor 2 (EIF2S1/eIF-2-alpha) and plays a key role in the
CC       innate immune response to viral infection (By similarity). Inhibits
CC       viral replication via the integrated stress response (ISR): EIF2S1/eIF-
CC       2-alpha phosphorylation in response to viral infection converts
CC       EIF2S1/eIF-2-alpha in a global protein synthesis inhibitor, resulting
CC       to a shutdown of cellular and viral protein synthesis, while
CC       concomitantly initiating the preferential translation of ISR-specific
CC       mRNAs, such as the transcriptional activator ATF4 (By similarity).
CC       Exerts its antiviral activity on a wide range of DNA and RNA viruses
CC       (By similarity). Also involved in the regulation of signal
CC       transduction, apoptosis, cell proliferation and differentiation:
CC       phosphorylates other substrates including p53/TP53, PPP2R5A, DHX9, ILF3
CC       and IRS1 (By similarity). In addition to serine/threonine-protein
CC       kinase activity, also has tyrosine-protein kinase activity and
CC       phosphorylates CDK1 at 'Tyr-4' upon DNA damage, facilitating its
CC       ubiquitination and proteasomal degradation (By similarity). Either as
CC       an adapter protein and/or via its kinase activity, can regulate various
CC       signaling pathways (p38 MAP kinase, NF-kappa-B and insulin signaling
CC       pathways) and transcription factors (JUN, STAT1, STAT3, IRF1, ATF3)
CC       involved in the expression of genes encoding pro-inflammatory cytokines
CC       and IFNs (By similarity). Activates the NF-kappa-B pathway via
CC       interaction with IKBKB and TRAF family of proteins and activates the
CC       p38 MAP kinase pathway via interaction with MAP2K6 (By similarity). Can
CC       act as both a positive and negative regulator of the insulin signaling
CC       pathway (ISP) (By similarity). Negatively regulates ISP by inducing the
CC       inhibitory phosphorylation of insulin receptor substrate 1 (IRS1) at
CC       'Ser-312' and positively regulates ISP via phosphorylation of PPP2R5A
CC       which activates FOXO1, which in turn up-regulates the expression of
CC       insulin receptor substrate 2 (IRS2) (By similarity). Can regulate NLRP3
CC       inflammasome assembly and the activation of NLRP3, NLRP1, AIM2 and
CC       NLRC4 inflammasomes (By similarity). Plays a role in the regulation of
CC       the cytoskeleton by binding to gelsolin (GSN), sequestering the protein
CC       in an inactive conformation away from actin (By similarity).
CC       {ECO:0000250|UniProtKB:P19525, ECO:0000250|UniProtKB:Q03963}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10027};
CC   -!- ACTIVITY REGULATION: Initially produced in an inactive form and is
CC       activated by binding to viral dsRNA, which causes dimerization and
CC       autophosphorylation in the activation loop and stimulation of function.
CC       ISGylation can activate it in the absence of viral infection. Can also
CC       be activated by heparin, pro-inflammatory stimuli, growth factors,
CC       cytokines, oxidative stress and the cellular protein PRKRA. Activity is
CC       markedly stimulated by manganese ions. Activation is blocked by the
CC       cellular proteins TARBP2, DUS2L, NPM1, NCK1 and ADAR (By similarity).
CC       {ECO:0000250|UniProtKB:P19525}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with DNAJC3 (By
CC       similarity). Interacts with STRBP. Forms a complex with FANCA, FANCC,
CC       FANCG and HSP70 (By similarity). Interacts with ADAR/ADAR1 (By
CC       similarity). The inactive form interacts with NCK1 and GSN. Interacts
CC       (via the kinase catalytic domain) with STAT3 (via SH2 domain), TRAF2
CC       (C-terminus), TRAF5 (C-terminus) and TRAF6 (C-terminus). Interacts with
CC       MAP2K6, IKBKB/IKKB, IRS1, NPM1, TARBP2, NLRP1, NLRP3, NLRC4 and AIM2.
CC       Interacts (via DRBM 1 domain) with DUS2L (via DRBM domain). Interacts
CC       with DHX9 (via N-terminus) and this interaction is dependent upon
CC       activation of the kinase (By similarity).
CC       {ECO:0000250|UniProtKB:P19525, ECO:0000250|UniProtKB:Q03963}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P19525}. Nucleus
CC       {ECO:0000250|UniProtKB:P19525}. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:P19525}.
CC   -!- PTM: Autophosphorylated on several Ser, Thr and Tyr residues.
CC       Autophosphorylation of Thr-411 is dependent on Thr-406 and is
CC       stimulated by dsRNA binding and dimerization. Autophosphorylation
CC       apparently leads to the activation of the kinase. Tyrosine
CC       autophosphorylation is essential for efficient dsRNA-binding,
CC       dimerization, and kinase activation (By similarity).
CC       {ECO:0000250|UniProtKB:P19525}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. GCN2 subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L29281; AAA61926.1; -; mRNA.
DR   PIR; S50216; S50216.
DR   RefSeq; NP_062208.1; NM_019335.1.
DR   AlphaFoldDB; Q63184; -.
DR   SMR; Q63184; -.
DR   BioGRID; 248507; 3.
DR   STRING; 10116.ENSRNOP00000071646; -.
DR   PhosphoSitePlus; Q63184; -.
DR   jPOST; Q63184; -.
DR   PaxDb; 10116-ENSRNOP00000067694; -.
DR   Ensembl; ENSRNOT00055038725; ENSRNOP00055031440; ENSRNOG00055022558.
DR   Ensembl; ENSRNOT00060023090; ENSRNOP00060018290; ENSRNOG00060013534.
DR   GeneID; 54287; -.
DR   KEGG; rno:54287; -.
DR   AGR; RGD:3402; -.
DR   CTD; 5610; -.
DR   RGD; 3402; Eif2ak2.
DR   eggNOG; KOG1033; Eukaryota.
DR   InParanoid; Q63184; -.
DR   OrthoDB; 8734at2759; -.
DR   PhylomeDB; Q63184; -.
DR   Reactome; R-RNO-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-RNO-9833482; PKR-mediated signaling.
DR   PRO; PR:Q63184; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003725; F:double-stranded RNA binding; ISO:RGD.
DR   GO; GO:0004694; F:eukaryotic translation initiation factor 2alpha kinase activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0016301; F:kinase activity; ISO:RGD.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004672; F:protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0140374; P:antiviral innate immune response; ISO:RGD.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; ISO:RGD.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0033689; P:negative regulation of osteoblast proliferation; ISS:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; ISS:UniProtKB.
DR   GO; GO:0045071; P:negative regulation of viral genome replication; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0032722; P:positive regulation of chemokine production; ISS:UniProtKB.
DR   GO; GO:0001819; P:positive regulation of cytokine production; ISS:UniProtKB.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0032874; P:positive regulation of stress-activated MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:1901532; P:regulation of hematopoietic progenitor cell differentiation; ISS:UniProtKB.
DR   GO; GO:1902036; P:regulation of hematopoietic stem cell differentiation; ISS:UniProtKB.
DR   GO; GO:1902033; P:regulation of hematopoietic stem cell proliferation; ISS:UniProtKB.
DR   GO; GO:1900225; P:regulation of NLRP3 inflammasome complex assembly; ISS:UniProtKB.
DR   GO; GO:0043330; P:response to exogenous dsRNA; IEP:RGD.
DR   GO; GO:0035455; P:response to interferon-alpha; ISS:UniProtKB.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IMP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IMP:RGD.
DR   GO; GO:0009615; P:response to virus; ISS:UniProtKB.
DR   GO; GO:0033197; P:response to vitamin E; IPI:RGD.
DR   GO; GO:0006412; P:translation; ISO:RGD.
DR   CDD; cd19903; DSRM_EIF2AK2_rpt1; 1.
DR   CDD; cd19904; DSRM_EIF2AK2_rpt2; 1.
DR   Gene3D; 3.30.160.20; -; 2.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR050339; CC_SR_Kinase.
DR   InterPro; IPR014720; dsRBD_dom.
DR   InterPro; IPR044452; EIF2AK2_DSRM_1.
DR   InterPro; IPR044453; EIF2AK2_DSRM_2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR11042; EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE EIF2-ALPHA KINASE -RELATED; 1.
DR   PANTHER; PTHR11042:SF163; INTERFERON-INDUCED, DOUBLE-STRANDED RNA-ACTIVATED PROTEIN KINASE; 1.
DR   Pfam; PF00035; dsrm; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00358; DSRM; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54768; dsRNA-binding domain-like; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50137; DS_RBD; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Antiviral defense; ATP-binding; Cytoplasm; Immunity;
KW   Innate immunity; Isopeptide bond; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; RNA-binding;
KW   Serine/threonine-protein kinase; Transcription; Transcription regulation;
KW   Transferase; Tyrosine-protein kinase; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
FT   CHAIN           2..513
FT                   /note="Interferon-induced, double-stranded RNA-activated
FT                   protein kinase"
FT                   /id="PRO_0000274915"
FT   DOMAIN          8..76
FT                   /note="DRBM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   DOMAIN          95..162
FT                   /note="DRBM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   DOMAIN          236..502
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          235..513
FT                   /note="Interaction with TRAF5"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
FT   ACT_SITE        373
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         242..250
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         265
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
FT   MOD_RES         84
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
FT   MOD_RES         96
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
FT   MOD_RES         157
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
FT   MOD_RES         227
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
FT   MOD_RES         262
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
FT   MOD_RES         406
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
FT   MOD_RES         411
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
FT   MOD_RES         416
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
FT   CROSSLNK        68
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ISG15)"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
FT   CROSSLNK        154
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ISG15)"
FT                   /evidence="ECO:0000250|UniProtKB:P19525"
SQ   SEQUENCE   513 AA;  58259 MW;  716751E84B7FED88 CRC64;
     MASDTPGFYV DKLNKYSQIH KVKIIYKEIS VTGPPHDRRF TFQVIIEERE FPEGEGRSKQ
     EAKNNAAKLA VEILDNENKV DSHTDASEQG LIEGNYIGLV NSFAQKENLP VNFELCDPDS
     QLPHRFICKC KIGQTTYGTG FGANKKEAKQ LAAKNAYQKL SEKSPSKTGF VTSLSSDFSS
     SSSITSNSAS QSASGRDFED IFMNGLREKR KSGVKVPSDD VLRNKYTLDD RFSKDFEDIE
     EIGSGGFGQV FKAKHRIDGK TYAIKRITYN TKKAKREVQA LAELNHANIV QYRVCWEGED
     YDYDPENSTN GDTSRYKTRC LFIQMEFCDK GTLQQWLEKR NRSQEDKALV LELFEQIVTG
     VDYIHSKGLI HRDLKPGNIF LVDEKHIKIG DFGLATALEN DGNPRTKYTG TPQYMSPEQK
     SSLVEYGKEV DIFALGLILA ELLHICKTDS EKIEFFQLLR NGIFSDDIFD NKEKSLLQKL
     LSSKPRERPN TSEILKTLAE WKNISEKKKR NTC
//
